Dr James Trevor Milliron, PHD | |
1201 Magnolia Ave Ne, Cleveland, TN 37311 | |
(423) 481-8394 | |
Not Available |
Full Name | Dr James Trevor Milliron |
---|---|
Gender | Male |
Speciality | Psychologist - Clinical |
Location | 1201 Magnolia Ave Ne, Cleveland, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124182548 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 1016 (Tennessee) | Secondary |
103TC0700X | Psychologist - Clinical | 2285 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James Trevor Milliron, PHD 1120 N Ocoee St, Cleveland, TN 37311-4475 Ph: (423) 614-8135 | Dr James Trevor Milliron, PHD 1201 Magnolia Ave Ne, Cleveland, TN 37311 Ph: (423) 481-8394 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market preservative-free Heparin Lock Flush Solution, USP in two dosage strengths, 10 USP Units/1 mL and 100 USP Units/1 mL, and will soon launch these single dose vial presentations.
There has been a major increase in the number of children diagnosed with autistic spectrum disorders over the last two decades - the question is why? Researchers have found a sharp difference between the beliefs of ordinary people and medical experts about the reasons for the increased incidence of autism.
When complications arise in the delivery room that lead to traumatic childbirth, clinicians providing care may feel upset and experience secondary traumatic stress. A new study published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, found that feelings of blame and guilt dominate when midwives and obstetricians struggle to cope with the aftermath of a traumatic childbirth, but such events also made them think more about the meaning of life and helped them become better midwives and doctors.
ProteaBio Europe SAS, a leading developer of new technology, announced today that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Legislation is promoting the development of healthcare IT infrastructure, while supporting efforts to enhance patient data privacy and security across the European healthcare spectrum.
› Verified 5 days ago